{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T07:50:13Z","timestamp":1793346613497,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100007316","name":"Division of Cancer Prevention, National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100007316","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1245\/s10434-026-19505-4","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T19:11:44Z","timestamp":1774293104000},"page":"5990-6000","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Hepatic Artery Infusion Pump Chemotherapy Associated Biliary Sclerosis After Treatment for Colorectal Cancer Liver Metastasis"],"prefix":"10.1245","volume":"33","author":[{"given":"Ankur P.","family":"Choubey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Seier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Schleimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad Bashir","family":"Barekzai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Zaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mithat","family":"G\u00f6nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin C.","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice C.","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod P.","family":"Balachandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Drebin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. Peter","family":"Kingham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Cercek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise C.","family":"Connell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy E.","family":"Kemeny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R.","family":"Jarnagin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael I.","family":"D\u2019Angelica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"key":"19505_CR1","unstructured":"Cancer of the Colon and Rectum - Cancer Stat Facts. SEER. Accessed June 7, 2025. https:\/\/seer.cancer.gov\/statfacts\/html\/colorect.html"},{"issue":"10","key":"19505_CR2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.36666","volume":"5","author":"N Reboux","year":"2022","unstructured":"Reboux N, Jooste V, Goungounga J, Robaszkiewicz M, Nousbaum JB, Bouvier AM. Incidence and survival in synchronous and metachronous liver metastases from colorectal cancer. JAMA Netw Open. 2022;5(10):e2236666. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.36666.","journal-title":"JAMA Netw Open."},{"issue":"1","key":"19505_CR3","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/j.1463-1318.2010.02539.x","volume":"14","author":"AEM van der Pool","year":"2012","unstructured":"van der Pool AEM, Damhuis RA, IJzermans JNM, et al. Trends in incidence, treatment and survival of patients with stage IV colorectal cancer: a population-based series. Colorectal Dis. 2012;14(1):56\u201361. https:\/\/doi.org\/10.1111\/j.1463-1318.2010.02539.x.","journal-title":"Colorectal Dis."},{"issue":"1","key":"19505_CR4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/jso.23371","volume":"109","author":"TL Frankel","year":"2014","unstructured":"Frankel TL, D\u2019Angelica MI. Hepatic resection for colorectal metastases. J Surg Oncol. 2014;109(1):2\u20137. https:\/\/doi.org\/10.1002\/jso.23371.","journal-title":"J Surg Oncol."},{"issue":"13","key":"19505_CR5","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1200\/JCO.2009.26.9340","volume":"28","author":"DG Power","year":"2010","unstructured":"Power DG, Kemeny NE. Role of adjuvant therapy after resection of colorectal cancer liver metastases. J Clin Oncol. 2010;28(13):2300\u20139. https:\/\/doi.org\/10.1200\/JCO.2009.26.9340.","journal-title":"J Clin Oncol."},{"issue":"27","key":"19505_CR6","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1056\/NEJM199912303412702","volume":"341","author":"N Kemeny","year":"1999","unstructured":"Kemeny N, Huang Y, Cohen AM, et al. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med. 1999;341(27):2039\u201348. https:\/\/doi.org\/10.1056\/NEJM199912303412702.","journal-title":"N Engl J Med."},{"issue":"6","key":"19505_CR7","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1002\/1097-0142(19930315)71:6<1964::AID-CNCR2820710607>3.0.CO;2-T","volume":"71","author":"N Kemeny","year":"1993","unstructured":"Kemeny N, Conti JA, Sigurdson E, et al. A pilot study of hepatic artery floxuridine combined with systemic 5-fluorouracil and leucovorin. A potential adjuvant program after resection of colorectal hepatic metastases. Cancer. 1993;71(6):1964\u201371.","journal-title":"Cancer"},{"issue":"6","key":"19505_CR8","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1097\/00000658-199812000-00006","volume":"228","author":"M Lorenz","year":"1998","unstructured":"Lorenz M, M\u00fcller HH, Schramm H, et al. Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. German cooperative on liver metastases (Arbeitsgruppe Lebermetastasen). Ann Surg. 1998;228(6):756\u201362. https:\/\/doi.org\/10.1097\/00000658-199812000-00006.","journal-title":"Ann Surg."},{"issue":"4","key":"19505_CR9","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1002\/1097-0142(19940215)73:4<1134::AID-CNCR2820730403>3.0.CO;2-V","volume":"73","author":"N Kemeny","year":"1994","unstructured":"Kemeny N, Seiter K, Conti JA, et al. Hepatic arterial floxuridine and leucovorin for unresectable liver metastases from colorectal carcinoma. New dose schedules and survival update. Cancer. 1994;73(4):1134\u201342.","journal-title":"Cancer"},{"issue":"7","key":"19505_CR10","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1200\/JCO.1992.10.7.1112","volume":"10","author":"P Rougier","year":"1992","unstructured":"Rougier P, Laplanche A, Huguier M, et al. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial. J Clin Oncol. 1992;10(7):1112\u20138. https:\/\/doi.org\/10.1200\/JCO.1992.10.7.1112.","journal-title":"J Clin Oncol."},{"issue":"4","key":"19505_CR11","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1002\/jso.24898","volume":"117","author":"LM Pak","year":"2018","unstructured":"Pak LM, Kemeny NE, Capanu M, et al. Prospective phase II trial of combination hepatic artery infusion and systemic chemotherapy for unresectable colorectal liver metastases: Long term results and curative potential. J Surg Oncol. 2018;117(4):634\u201343. https:\/\/doi.org\/10.1002\/jso.24898.","journal-title":"J Surg Oncol."},{"issue":"2","key":"19505_CR12","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/jso.20286","volume":"91","author":"N Kemeny","year":"2005","unstructured":"Kemeny N, Eid A, Stockman J, et al. Hepatic arterial infusion of floxuridine and dexamethasone plus high-dose Mitomycin C for patients with unresectable hepatic metastases from colorectal carcinoma. J Surg Oncol. 2005;91(2):97\u2013101. https:\/\/doi.org\/10.1002\/jso.20286.","journal-title":"J Surg Oncol."},{"issue":"22","key":"19505_CR13","doi-asserted-by":"publisher","first-page":"4888","DOI":"10.1200\/JCO.2005.07.100","volume":"23","author":"N Kemeny","year":"2005","unstructured":"Kemeny N, Jarnagin W, Paty P, et al. Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer. J Clin Oncol. 2005;23(22):4888\u201396. https:\/\/doi.org\/10.1200\/JCO.2005.07.100.","journal-title":"J Clin Oncol."},{"issue":"9","key":"19505_CR14","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1200\/JCO.2005.03.8166","volume":"24","author":"NE Kemeny","year":"2006","unstructured":"Kemeny NE, Niedzwiecki D, Hollis DR, et al. Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481). J Clin Oncol. 2006;24(9):1395\u2013403. https:\/\/doi.org\/10.1200\/JCO.2005.03.8166.","journal-title":"J Clin Oncol."},{"issue":"21","key":"19505_CR15","doi-asserted-by":"publisher","first-page":"3465","DOI":"10.1200\/JCO.2008.20.1301","volume":"27","author":"NE Kemeny","year":"2009","unstructured":"Kemeny NE, Melendez FDH, Capanu M, et al. Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma. J Clin Oncol. 2009;27(21):3465\u201371. https:\/\/doi.org\/10.1200\/JCO.2008.20.1301.","journal-title":"J Clin Oncol."},{"key":"19505_CR16","unstructured":"The Netherlands Cancer Institute. Hepatic Arterial Infusion PUMP Chemotherapy Combined With Systemic Therapy Versus Systemic Therapy Alone as Induction Therapy for Initially Unresectable Colorectal Liver Metastases: A Randomised Controlled Trial. clinicaltrials.gov; 2025. Accessed June 8, 2025. https:\/\/clinicaltrials.gov\/study\/NCT06857773"},{"key":"19505_CR17","unstructured":"ECOG-ACRIN Cancer Research Group. A Randomized Phase III Study of Systemic Therapy With or Without Hepatic Arterial Infusion for Unresectable Colorectal Liver Metastases: The PUMP Trial. clinicaltrials.gov; 2024. Accessed June 7, 2025. https:\/\/clinicaltrials.gov\/study\/NCT05863195"},{"key":"19505_CR18","unstructured":"Lassen K. EXtended CriteriA Treatment for LIver Metastases With Heavy Tumour BURden 1 + 2. clinicaltrials.gov; 2024. Accessed June 8, 2025. https:\/\/clinicaltrials.gov\/study\/NCT04898504"},{"key":"19505_CR19","unstructured":"Memorial Sloan Kettering Cancer Center. A Randomized Phase II Study of Systemic Chemotherapy With or Without HAI FUDR&#x2F;Dexamethasone in Patients With Unresectable Intrahepatic Cholangiocarcinoma. clinicaltrials.gov; 2025. Accessed June 8, 2025. https:\/\/clinicaltrials.gov\/study\/NCT04891289"},{"issue":"11","key":"19505_CR20","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1200\/JCO.1989.7.11.1646","volume":"7","author":"DC Hohn","year":"1989","unstructured":"Hohn DC, Stagg RJ, Friedman MA, et al. A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial. J Clin Oncol. 1989;7(11):1646\u201354. https:\/\/doi.org\/10.1200\/JCO.1989.7.11.1646.","journal-title":"J Clin Oncol."},{"issue":"1","key":"19505_CR21","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1200\/JCO.1985.3.1.98","volume":"3","author":"D Hohn","year":"1985","unstructured":"Hohn D, Melnick J, Stagg R, et al. Biliary sclerosis in patients receiving hepatic arterial infusions of floxuridine. J Clin Oncol. 1985;3(1):98\u2013102. https:\/\/doi.org\/10.1200\/JCO.1985.3.1.98.","journal-title":"J Clin Oncol."},{"issue":"6","key":"19505_CR22","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1097\/00000658-198712000-00001","volume":"206","author":"AE Chang","year":"1987","unstructured":"Chang AE, Schneider PD, Sugarbaker PH, Simpson C, Culnane M, Steinberg SM. A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg. 1987;206(6):685\u201393. https:\/\/doi.org\/10.1097\/00000658-198712000-00001.","journal-title":"Ann Surg."},{"issue":"2","key":"19505_CR23","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1097\/00000658-198508000-00007","volume":"202","author":"MM Kemeny","year":"1985","unstructured":"Kemeny MM, Battifora H, Blayney DW, et al. Sclerosing cholangitis after continuous hepatic artery infusion of FUDR. Ann Surg. 1985;202(2):176\u201381. https:\/\/doi.org\/10.1097\/00000658-198508000-00007.","journal-title":"Ann Surg."},{"issue":"5","key":"19505_CR24","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1245\/s10434-011-2102-8","volume":"19","author":"K Ito","year":"2012","unstructured":"Ito K, Ito H, Kemeny NE, et al. Biliary sclerosis after hepatic arterial infusion pump chemotherapy for patients with colorectal cancer liver metastasis: Incidence, clinical features, and risk factors. Ann Surg Oncol. 2012;19(5):1609\u201317. https:\/\/doi.org\/10.1245\/s10434-011-2102-8.","journal-title":"Ann Surg Oncol."},{"issue":"7","key":"19505_CR25","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1038\/sj.bjc.6602102","volume":"91","author":"JM Satagopan","year":"2004","unstructured":"Satagopan JM, Ben-Porat L, Berwick M, Robson M, Kutler D, Auerbach AD. A note on competing risks in survival data analysis. Br J Cancer. 2004;91(7):1229\u201335. https:\/\/doi.org\/10.1038\/sj.bjc.6602102.","journal-title":"Br J Cancer."},{"issue":"8","key":"19505_CR26","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1158\/1078-0432.CCR-12-0455","volume":"18","author":"R Chappell","year":"2012","unstructured":"Chappell R. Competing risk analyses: how are they different and why should you care? Clin Cancer Res. 2012;18(8):2127\u20139. https:\/\/doi.org\/10.1158\/1078-0432.CCR-12-0455.","journal-title":"Clin Cancer Res."},{"issue":"2","key":"19505_CR27","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1200\/OP.23.00374","volume":"20","author":"D Rao","year":"2024","unstructured":"Rao D, Ellis CS, Kemeny N, Cercek A. Case-based clinical guidance on dosing and management of the hepatic artery infusion chemotherapy pump. JCO Oncol Pract. 2024;20(2):187\u201394. https:\/\/doi.org\/10.1200\/OP.23.00374.","journal-title":"JCO Oncol Pract."},{"issue":"2","key":"19505_CR28","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/1097-0142(19920115)69:2<327::AID-CNCR2820690209>3.0.CO;2-U","volume":"69","author":"N Kemeny","year":"1992","unstructured":"Kemeny N, Seiter K, Niedzwiecki D, et al. A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer. Cancer. 1992;69(2):327\u201334.","journal-title":"Cancer."},{"issue":"3","key":"19505_CR29","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1097\/00000658-198403000-00011","volume":"199","author":"JG Fortner","year":"1984","unstructured":"Fortner JG, Silva JS, Cox EB, Golbey RB, Gallowitz H, Maclean BJ. Multivariate analysis of a personal series of 247 patients with liver metastases from colorectal cancer. II. Treatment by intrahepatic chemotherapy. Ann Surg. 1984;199(3):317\u201324. https:\/\/doi.org\/10.1097\/00000658-198403000-00011.","journal-title":"Ann Surg."},{"issue":"2","key":"19505_CR30","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1097\/00000658-197308000-00009","volume":"178","author":"JG Fortner","year":"1973","unstructured":"Fortner JG, Mulcare RJ, Solis A, Watson RC, Golbey RB. Treatment of primary and secondary liver cancer by hepatic artery ligation and infusion chemotherapy. Ann Surg. 1973;178(2):162\u201372. https:\/\/doi.org\/10.1097\/00000658-197308000-00009.","journal-title":"Ann Surg."},{"issue":"11","key":"19505_CR31","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1002\/1097-0142(19830601)51:11<2013::AID-CNCR2820511109>3.0.CO;2-#","volume":"51","author":"AM Cohen","year":"1983","unstructured":"Cohen AM, Greenfield A, Wood WC, et al. Treatment of hepatic metastases by transaxillary hepatic artery chemotherapy using an implanted drug pump. Cancer. 1983;51(11):2013\u20139.","journal-title":"Cancer."},{"issue":"9","key":"19505_CR32","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1200\/JCO.1986.4.9.1356","volume":"4","author":"YZ Patt","year":"1986","unstructured":"Patt YZ, Boddie AW Jr, Charnsangavej C, Ajani JA, Wallace S, Soski M, Mavligit GM. Hepatic arterial infusion with floxuridine and cisplatin: overriding importance of antitumor effect versus degree of tumor burden as determinants of survival among patients with colorectal cancer. J Clin Oncol. 1986;4(9):1356\u201364. https:\/\/doi.org\/10.1200\/JCO.1986.4.9.1356.","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"19505_CR33","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1200\/JCO.1985.3.9.1257","volume":"3","author":"DC Hohn","year":"1985","unstructured":"Hohn DC, Stagg RJ, Price DC, Lewis BJ. Avoidance of gastroduodenal toxicity in patients receiving hepatic arterial 5-fluoro-2\u2019-deoxyuridine. J Clin Oncol. 1985;3(9):1257\u201360. https:\/\/doi.org\/10.1200\/JCO.1985.3.9.1257.","journal-title":"J Clin Oncol."},{"issue":"2","key":"19505_CR34","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1200\/JCO.1993.11.2.330","volume":"11","author":"N Kemeny","year":"1993","unstructured":"Kemeny N, Cohen A, Seiter K, et al. Randomized trial of hepatic arterial floxuridine, mitomycin, and carmustine versus floxuridine alone in previously treated patients with liver metastases from colorectal cancer. J Clin Oncol. 1993;11(2):330\u20135. https:\/\/doi.org\/10.1200\/JCO.1993.11.2.330.","journal-title":"J Clin Oncol."},{"issue":"2","key":"19505_CR35","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1097\/SLA.0000000000000614","volume":"261","author":"MI D\u2019Angelica","year":"2015","unstructured":"D\u2019Angelica MI, Correa-Gallego C, Paty PB, et al. Phase II trial of hepatic artery infusional and systemic chemotherapy for patients with unresectable hepatic metastases from colorectal cancer: Conversion to resection and long-term outcomes. Ann Surg. 2015;261(2):353\u201360. https:\/\/doi.org\/10.1097\/SLA.0000000000000614.","journal-title":"Ann Surg."},{"issue":"7","key":"19505_CR36","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1200\/JCO.2010.32.5977","volume":"29","author":"NE Kemeny","year":"2011","unstructured":"Kemeny NE, Jarnagin WR, Capanu M, et al. Randomized phase II trial of adjuvant hepatic arterial infusion and systemic chemotherapy with or without bevacizumab in patients with resected hepatic metastases from colorectal cancer. J Clin Oncol. 2011;29(7):884\u20139. https:\/\/doi.org\/10.1200\/JCO.2010.32.5977.","journal-title":"J Clin Oncol."},{"issue":"11","key":"19505_CR37","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1200\/JCO.1994.12.11.2288","volume":"12","author":"N Kemeny","year":"1994","unstructured":"Kemeny N, Conti JA, Cohen A, Campana P, Huang Y, Shi WJ, Bertino JR. Phase II study of hepatic arterial floxuridine, leucovorin, and dexamethasone for unresectable liver metastases from colorectal carcinoma. J clin Oncol. 1994;12(11):2288\u201395. https:\/\/doi.org\/10.1200\/JCO.1994.12.11.2288.","journal-title":"J clin Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-19505-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-19505-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-19505-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T15:51:55Z","timestamp":1780761115000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-026-19505-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["19505"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-19505-4","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,23]]},"assertion":[{"value":"19 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Alice Wei: Histosonics \u2013 DSMB member; Ipsen \u2013 Institutional clinical trial funding; Medtronic \u2013 Honorarium. Louise Connell: Consulting work for Intera Oncology and Boston Scientific. This work was funded in part by NIH\/National Cancer Institute Cancer Center Support grant [P30 CA008748]. Andrea Cercek: advisory boards for Amgen, AbbVie, Agenus, Daiichi-Saynko, Merck, GSK, Pfizer, Roche, Janssen, Summit, 3T Biosciences, Urogen and Regeneron and research funding from GKS and Pfizer.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}